IDXX Q3 2018 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$47B

Q3 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$545M+10.9% YoY

Gross Profit

$306M56.0% margin

Operating Income

$117M21.5% margin

Net Income

$93M17.1% margin

EPS (Diluted)

$1.05

QoQ Revenue Growth

-6.1%

Cash Flow

Operating Cash Flow

$111M

Free Cash Flow

$79M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$1.5B

Stockholders' Equity

-$2M

Cash & Equivalents

$147M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$545M	$492M	+10.9%
Gross Profit	$306M	$274M	+11.5%
Operating Income	$117M	$100M	+16.9%
Net Income	$93M	$71M	+32.3%

Revenue Segments

Up Front Customer Loyalty Programs And Volume Commitment Programs

$1.1B93%

Reagent Rental Programs

$55M5%

Extended Warranties And Post Contract Support

$28M2%

Instrument Rebate Programs

$5M0%

Geographic Segments

UNITED STATES

$341M79%

Asia Pacific

$57M13%

CANADA

$22M5%

Latin America

$13M3%